Refractory warts: topical or intralesional cidofovir options

Published Date: 02 Mar 2023

New research suggests that cidofovir may be a helpful option for tender joints or joints.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The clinical trial of ENZAMET shows promise as a treatment for prostate cancer.

2.

'It's rare and it's scary.' Dark spot on your fingernail could mean cancer

3.

Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer

4.

Experts say oncology, primary care coordination necessary for best cancer patient outcomes

5.

How a California Oncologist Making $850k Spends Money


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot